Exhibit 99.1
FOR IMMEDIATE RELEASE
Investor Relations Contact: | | Media Contact: |
Terry Slavin | | Kelly Hamor |
Director, Corp. Communications & IR | | Formula |
Cymer, Inc. | | (619) 234-0345 |
(858) 385-5232 | | Hamor@formulapr.com |
tslavin@cymer.com | | |
CYMER REPORTS FIRST QUARTER 2008 OPERATING RESULTS
SAN DIEGO, Calif., April 22, 2008 - Cymer, Inc. (Nasdaq: CYMI), the world’s leading supplier of light sources used in semiconductor lithography, today announced operating results for the first quarter ended March 31, 2008.
For the first quarter of 2008:
· net income totaled $12,892,000, equal to $0.41 per share (diluted), compared to net income of $20,321,000, equal to $0.52 per share (diluted) in the first quarter of 2007 and net income of $21,437,000, equal to $0.67 per share (diluted) in the fourth quarter of 2007.
· revenue totaled $123,952,000 compared to revenue of $126,714,000 in the prior year’s first quarter, and revenue of $139,922,000 in the fourth quarter of 2007.
Commenting on first quarter results, Bob Akins, Cymer’s chief executive officer, said, “Total revenue for the first quarter of 2008 came in at approximately $124 million, driven by adoption of our latest argon fluoride (ArF) immersion light source, the XLR 500i, and higher than anticipated non-systems revenue. Our non-systems revenue for the first quarter grew to $79.0 million, driven by continuing high utilization in all three chipmaker sectors.”
Akins continued, “Chipmaker push-outs of lithography tools into late 2008 and 2009 affected the build plans of our direct customers, and brought about a reduction in demand for light sources in the first quarter of 2008. Our first quarter 2008 shipments of 31 light sources included 24 XL Series argon fluoride (ArF) sources, with 13 of them, or 54 percent, being immersion light sources. We were pleased to see the number of XLR 500i light sources shipped in the first quarter triple compared to the previous quarter. With the product mix shifting to our XL platform products, our average selling price on a currency adjusted basis rose to $1.44 million.”
The company reported gross profit on product sales of $59.7 million, yielding a 48.3 percent gross margin in the first quarter of 2008, and recorded operating income of $19.7 million, yielding a 15.9 percent operating margin.
Nancy Baker, Cymer’s chief financial officer, stated, “Deep ultraviolet (DUV) bookings for the first quarter of 2008 totaled $101.1 million, resulting in a book-to-bill ratio of 0.82. Approximately 53 percent of the units and 83 percent of the value of bookings in the first quarter were ArF. We ended the quarter with a DUV backlog of approximately $76.7 million, with ArF comprising approximately 65 percent of the units, and 85 percent of the value of systems in backlog. Additionally, approximately 65 percent of the value of systems in backlog at quarter-end is attributable to ArF immersion, up substantially from 55 percent in the fourth quarter of 2007.”
Baker continued, “Our net income for the first quarter of 2008 includes an impairment charge of $3.8 million on our sole investment in auction rate securities. This impairment was recorded in order to properly reflect the fair value of this auction rate security, given the current credit market crisis.”
–more–
CYMER REPORTS FIRST QUARTER 2008 OPERATING RESULTS | | Page 2 of 6 |
Corporate Outlook
Commenting on the industry’s outlook, Akins noted, “There is growing speculation that the U.S. economy has already entered a recession. U.S. consumers, under increasing pressure from lower real estate values, tighter credit and higher energy and food prices, find themselves with less discretionary income. These macroeconomic factors are affecting the industry world wide.”
Akins continued, “Though the current cyclical environment is challenging, Cymer is well positioned as growing numbers of chipmakers adopt and ramp ArF immersion, and continue rapidly moving toward adoption of ArF double patterning and the evaluation of extreme ultraviolet (EUV) technology. Near term, the adoption cycle for the XLR Series of products is gaining momentum. Medium term, we anticipate the 90W XLR 600i will become the light source of choice for double patterning at the 32nm node. Longer term, the success of our laser produced plasma (LPP) source development has positioned us as the EUV technology leader. Finally, there is the potential for significant ongoing growth of our non-systems revenue. This is driven not only by increasing pulse counts and our growing installed base, but increasingly by our continuing efforts to bring to our customers higher performance features and upgrades aimed at providing substantial improvements in uptime, availability and cost.”
Based on information available at this time, Cymer is currently providing the following guidance for the second quarter of 2008, and anticipates:
· Total revenue to be comparable to the revenue reported for Q1 2008.
· Foreign currency adjusted ASP to remain at approximately $1.4 million, based on continuing strong demand for XLA and XLR light sources for immersion applications.
· Gross margin to remain at approximately 48 percent.
· Research and development (R&D) expenses to be between $25.5 and $26.5 million as we continue to commercialize our EUV source and TCZ technologies.
· Selling, general and administrative expenses to be between $17.5 million and $18.0 million.
· The estimated annual effective tax rate to be approximately 37 percent.
Cymer’s management will hold a conference call at 2:00 pm (PDT) today, April 22, 2008, to discuss first quarter 2008 operating results and provide second quarter 2008 guidance. This press release, the conference call and accompanying slides may be accessed on the investor relations page of the company’s Web site at www.cymer.com.
Forward Looking Statements
Statements in this press release that are not strictly historical in nature are forward-looking statements. These statements include, but are not limited to statements regarding push-outs of lithography tools, and the statements under the caption “Corporate Outlook” above. These statements are predictions based on current information and expectations and involve a number of risks and uncertainties. In addition, statements regarding backlog and book-to-bill ratios should not be read as predictions or projections of future performance. Actual events or results may differ materially from those projected in any of such statements due to various factors, including but not limited to: the demand for semiconductors in general, and, in particular, for leading-edge devices with smaller geometries; cyclicality in the market for semiconductor manufacturing equipment; the timing of customer orders, shipments and acceptances; delays or cancellations by customers of their orders, the performance and market acceptance of the company’s new products or technologies; new and enhanced product offerings by competitors; the company’s ability to meet its production and product development schedules; the rate at which semiconductor manufacturers adopt new technologies and purchase and take delivery of photolithography tools from the company’s customers; the company’s ability to secure adequate supplies of critical components for its advanced products; the company’s ability to manage its expense levels and unanticipated expenses, the performance and conditions in the United States and world financial markets; the policies and actions of the United States and other governments; and general economic conditions. For a discussion of these and other factors which may cause our actual events or results to differ from those projected, please refer to the company’s most recent annual report on Form 10-K and quarterly reports on Form 10-Q, as well as other subsequent filings with the Securities and Exchange Commission. You are cautioned
- more -
CYMER REPORTS FIRST QUARTER 2008 OPERATING RESULTS | | Page 3 of 6 |
not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. All forward-looking statements are qualified in their entirety by this cautionary statement, and the company undertakes no obligation to revise or update any forward-looking statements to reflect events or circumstances after the date of this press release.
About Cymer
Cymer, Inc. is the world’s leading supplier of DUV laser illumination sources, the essential light source for DUV photolithography systems. DUV lithography is a key enabling technology, which has allowed the semiconductor industry to meet the exacting specifications and manufacturing requirements for volume production of today’s advanced semiconductor chips. Further information on Cymer may be obtained from the Company’s SEC filings, the Internet at www.cymer.com or by contacting the company directly.
| | Three Months Ended March 31 | |
| | 2007 | | 2008 | |
Cymer, Inc. | | | | | |
Total revenues | | $ | 126,714,000 | | $ | 123,952,000 | |
| | | | | |
Net income | | $ | 20,321,000 | | $ | 12,892,000 | |
Diluted earnings per share | | $ | 0.52 | | $ | 0.41 | |
Weighted average common shares outstanding - diluted | | 40,617,000 | | 33,240,000 | |
- more -
CYMER REPORTS FIRST QUARTER 2008 OPERATING RESULTS | | Page 4 of 6 |
CYMER, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)
(In thousands, except per share data)
| | For the three months | |
| | ended March 31, | |
| | 2007 | | 2008 | |
REVENUES: | | | | | |
Product sales | | $ | 126,159 | | $ | 122,878 | |
Product sales - related party | | 466 | | 921 | |
Other | | 89 | | 153 | |
Total revenues | | 126,714 | | 123,952 | |
| | | | | |
COST AND EXPENSES: | | | | | |
Cost of product sales | | 65,066 | | 64,056 | |
Research and development | | 19,302 | | 22,765 | |
Sales and marketing | | 6,969 | | 6,834 | |
General and administrative | | 8,810 | | 10,563 | |
| | | | | |
Total costs and expenses | | 100,147 | | 104,218 | |
| | | | | |
OPERATING INCOME | | 26,567 | | 19,734 | |
| | | | | |
OTHER INCOME (EXPENSE): | | | | | |
Foreign currency exchange gain - net | | 427 | | 1,709 | |
Write-down of investments | | — | | (3,806 | ) |
Interest and other income | | 6,417 | | 3,347 | |
Interest and other expense | | (1,579 | ) | (1,760 | ) |
| | | | | |
Total other income (expense) - net | | 5,265 | | (510 | ) |
| | | | | |
INCOME BEFORE INCOME TAX PROVISION AND MINORITY INTEREST | | 31,832 | | 19,224 | |
| | | | | |
INCOME TAX PROVISION | | 12,227 | | 7,113 | |
MINORITY INTEREST | | 716 | | 781 | |
| | | | | |
NET INCOME | | $ | 20,321 | | $ | 12,892 | |
| | | | | |
EARNINGS PER SHARE: | | | | | |
Basic earnings per share | | $ | 0.55 | | $ | 0.43 | |
Weighted average common shares outstanding-basic | | 37,269 | | 30,315 | |
| | | | | |
Diluted earnings per share | | $ | 0.52 | (a) | $ | 0.41 | (a) |
Weighted average common shares outstanding-diluted | | 40,617 | (a) | 33,240 | (a) |
(a) As a result of applying the if-converted method for calculating diluted earnings per share for both of the three month periods ended March 31, 2007 and March 31, 2008, shares have been adjusted assuming conversion of our 3.5% convertible subordinated notes,and net income has been adjusted for an add back of related interest expense, net of tax. Shares have been adjusted by 2.8 million for both the three months ended March 31, 2007 and March 31, 2008 and net income has been adjusted by $822,000 and $841,000 for the three months ended March 31, 2007 and March 31, 2008, respectively.
- more -
CYMER REPORTS FIRST QUARTER 2008 OPERATING RESULTS | | Page 5 of 6 |
CYMER, INC.
CONSOLIDATED BALANCE SHEETS (UNAUDITED)
(In thousands, except share data)
| | December 31, | | March 31, | |
| | 2007 | | 2008 | |
ASSETS | | | | | |
| | | | | |
CURRENT ASSETS: | | | | | |
Cash and cash equivalents | | $ | 305,707 | | $ | 238,584 | |
Short-term investments | | 22,355 | | 84,648 | |
Accounts receivable - net | | 91,875 | | 73,820 | |
Accounts receivable - related party | | 1,112 | | 2,800 | |
Foreign currency forward exchange contracts | | 2 | | — | |
Inventories | | 129,757 | | 153,129 | |
Deferred income taxes | | 42,147 | | 42,770 | |
Prepaid expenses and other assets | | 8,928 | | 12,166 | |
| | | | | |
Total current assets | | 601,883 | | 607,917 | |
| | | | | |
PROPERTY AND EQUIPMENT - NET | | 116,725 | | 121,164 | |
LONG TERM INVESTMENTS | | 29,443 | | 22,382 | |
DEFERRED INCOME TAXES | | 19,272 | | 19,338 | |
GOODWILL - NET | | 8,833 | | 8,833 | |
INTANGIBLE ASSETS - NET | | 12,951 | | 12,188 | |
OTHER ASSETS | | 5,045 | | 3,650 | |
| | | | | |
TOTAL ASSETS | | $ | 794,152 | | $ | 795,472 | |
| | | | | |
LIABILITIES AND STOCKHOLDERS’ EQUITY | | | | | |
| | | | | |
CURRENT LIABILITIES: | | | | | |
Accounts payable | | $ | 23,980 | | 27,972 | |
Accounts payable - related party | | 4,428 | | 2,670 | |
Accrued warranty and installation | | 24,832 | | 26,334 | |
Accrued payroll and benefits | | 24,406 | | 19,674 | |
Accrued patents, royalties and other fees | | 3,303 | | 4,269 | |
Convertible subordinated notes | | — | | 140,722 | |
Income taxes payable | | 13,468 | | 7,265 | |
Deferred revenue | | 4,974 | | 7,714 | |
Foreign currency forward exchange contracts | | 170 | | 1,840 | |
Accrued and other current liabilities | | 3,917 | | 2,285 | |
| | | | | |
Total current liabilities | | 103,478 | | 240,745 | |
| | | | | |
CONVERTIBLE SUBORDINATED NOTES | | 140,722 | | — | |
INCOME TAXES PAYABLE | | 17,755 | | 17,272 | |
DEFERRED REVENUE | | 5,562 | | 4,100 | |
OTHER LIABILITIES | | 17,401 | | 15,842 | |
| | | | | |
Total liabilities | | 284,918 | | 277,959 | |
| | | | | |
MINORITY INTEREST | | 5,711 | | 4,929 | |
| | | | | |
COMMITMENTS AND CONTINGENCIES | | | | | |
| | | | | |
STOCKHOLDERS’ EQUITY: | | | | | |
Preferred stock - authorized 5,000,000 shares; $.001 par value, no shares issued or outstanding | | — | | — | |
Common stock - authorized 100,000,000 shares; $.001 par value, 42,339,000 and 42,381,000 shares outstanding at December 31, 2007 and March 31, 2008, respectively | | 42 | | 42 | |
Additional paid-in capital | | 579,711 | | 581,793 | |
Treasury stock at cost (12,049,000 common shares) | | (450,704 | ) | (450,704 | ) |
Accumulated other comprehensive income (loss) | | 214 | | (5,699 | ) |
Retained earnings | | 374,260 | | 387,152 | |
| | | | | |
Total stockholders’ equity | | 503,523 | | 512,584 | |
| | | | | |
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY | | $ | 794,152 | | $ | 795,472 | |
- more -
CYMER REPORTS FIRST QUARTER 2008 OPERATING RESULTS | | Page 6 of 6 |
CYMER, INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)
(In thousands)
| | For the three months | |
| | ended March 31, | |
| | 2007 | | 2008 | |
| | | | | |
OPERATING ACTIVITIES: | | | | | |
Net income | | $ | 20,321 | | $ | 12,892 | |
Adjustments to reconcile net income to net cash provided by operating activities: Depreciation and amortization | | 6,364 | | 6,727 | |
Non-cash stock based compensation | | 1,356 | | 1,565 | |
Minority interest | | (716 | ) | (781 | ) |
Provision for deferred income taxes | | 8,089 | | (689 | ) |
Loss on disposal or impairment of property and equipment | | 5 | | — | |
Write-down of investments | | — | | 3,806 | |
Change in assets and liabilities: | | | | | |
Accounts receivable - net | | 2,775 | | 18,055 | |
Accounts receivable - related party | | (878 | ) | (1,688 | ) |
Foreign currency forward exchange contracts | | 606 | | 881 | |
Inventories | | (7,871 | ) | (23,372 | ) |
Prepaid expenses and other assets | | (762 | ) | (2,038 | ) |
Accounts payable | | 3,763 | | 3,992 | |
Accounts payable - related party | | (646 | ) | (1,758 | ) |
Accrued and other liabilities | | (4,889 | ) | (5,455 | ) |
Deferred income | | 237 | | 1,278 | |
Income taxes payable | | (610 | ) | (6,549 | ) |
| | | | | |
Net cash provided by operating activities | | 27,144 | | 6,866 | |
| | | | | |
INVESTING ACTIVITIES: | | | | | |
Acquisition of property and equipment | | (4,114 | ) | (10,208 | ) |
Purchases of investments | | (38,834 | ) | (70,080 | ) |
Proceeds from sold or matured investments | | 39,974 | | 11,523 | |
| | | | | |
Net cash used in investing activities | | (2,974 | ) | (68,765 | ) |
| | | | | |
FINANCING ACTIVITIES: | | | | | |
Proceeds from issuance of common stock | | 1,254 | | 577 | |
Excess tax benefits from stock option exercises | | 313 | | (60 | ) |
| | | | | |
Net cash provided by financing activities | | 1,567 | | 517 | |
| | | | | |
EFFECT OF EXCHANGE RATE CHANGES ON CASH AND CASH EQUIVALENTS | | (25 | ) | (5,741 | ) |
| | | | | |
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | | 25,712 | | (67,123 | ) |
CASH AND CASH EQUIVALENTS AT BEGINNING OF THE PERIOD | | 302,098 | | 305,707 | |
| | | | | |
CASH AND CASH EQUIVALENTS AT END OF THE PERIOD | | $ | 327,810 | | $ | 238,584 | |
| | | | | |
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION: | | | | | |
Interest paid | | $ | 2,551 | | $ | 2,659 | |
Income taxes paid, net | | $ | 4,202 | | $ | 14,896 | |
###